Aerosol Inhalation Treatment for Dyspnea - Patients
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to develop and test aerosol furosemide, as a treatment that
has the potential to significantly improve symptom management and enhance the quality of care
for patients with intractable dyspnea.